AI system for diabetes treatment

I reported previously (see here) on Israel’s DreaMed Diabetes monitors. DreaMed has just partnered with French company BioCorp to create an Artificially Intelligent system that integrates BioCorp’s Mallya smart cap for pen injectors with DreaMed’s Advisor Pro insulin analysis system.

https://www.businesswire.com/news/home/20190220005514/en/BIOCORP-DreaMed-Diabetes-Join-Offer-Outstanding-AI

https://dreamed-diabetes.com/advisor/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *